🕵️ Redhill Biopharma Ltd. ($RDHL)
SEC insider & ownership activity, last 12 months · CIK 1553846 · every row links its SEC filing
Over the last 12 months insiders sold $3K with no open-market buying against it. Raday Gilead sold $3K in discretionary trades (Apr–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $3K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Raday Gilead | 0 | – | 2 | $3K | Jul 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Alumni Capital LP | 10.0% | 13G | Oct 20, 2025 | filing ↗ | |
| Alumni Capital GP LLC | 10.0% | 13G | Oct 20, 2025 | filing ↗ | |
| Ashkan Mapar | 10.0% | 13G | Oct 20, 2025 | filing ↗ | |
| YA II PN, Ltd. | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| YA Global Investments II (U.S.), LP | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| Yorkville Advisors Global, LP | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| Yorkville Advisors Global II, LLC | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| YAII GP, LP | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| YAII GP II, LLC | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| Mark Angelo | 9.9% | 13G | Dec 23, 2025 | filing ↗ | |
| Sc-Sigma Global Partners, LP | 9.9% | 13G | Dec 23, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.